Rocket Pharmaceuticals's total assets for Q4 2025 were $330.45M, a decrease of -10.21% from the previous quarter. DE:9IP1 total liabilities were $53.23M for the fiscal quarter, a -2.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.